Mobile listening therapy for young people with cochlear implants
Tests a mobile listening therapy in young cochlear implant users.
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users
- Status
- Not yet recruiting
- People taking part
- 25 people, planned
- Started
- 22 Dec 2025
- Planned end
- 31 Aug 2026
- Type of study
- Interventional
- Treatments tested
- Mobile Auditory Rehabilitation
- Record updated
- 22 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Korean children and teenagers with cochlear implants. They will use a mobile hearing training app (Wowfit) for 12 weeks, followed by 12 weeks of follow-up.
- Age
- 10 to 19 years
- Sex
- All sexes
- Disease stage
- People who have a cochlear implant (a hearing device placed by surgery) and hearing loss.
- Earlier treatment
- People who had a repeat (revision) cochlear implant surgery cannot join. People who have used the study's hearing training app before cannot join.
- Biomarker or test result
- A score of ≤80% on the MCI test before the study. People must be able to use a smartphone.
Main reasons for not taking part
- Serious body-wide illness (for example cancer, stroke) that limits daily life
- Intellectual disability, birth defects or other nerve disorders that affect language or thinking
- Diagnosed emotional disorders such as depression or anxiety
- Using mainly sign language to communicate every day
- Past cochlear implant revision surgery
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Individuals with cochlear implants
- Korean patients aged 10 to 19 years
- Capable of using a smartphone
- Scored ≤80% on MCI pre-assessment
- Voluntarily agreed to participate in this study
Who cannot take part
- Has undergone cochlear implant revision surgery
- Has prior experience with the investigational auditory rehabilitation application used in this study
- Has systemic medical conditions (e.g., cancer, stroke) that limit daily functioning
- Has intellectual disability, congenital malformation, or other neurological disorders affecting language or cognitive abilities
- Has diagnosed emotional disorders such as depression or anxiety
- Primarily uses sign language for daily communication
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 19 years old?
Where in South Korea
- Seoul National University HospitalSeoul, South KoreaContact: Sang-Yeon Lee, MD, PhDNot yet recruiting
About the trial
What the trial wants to find out
This exploratory, single-center, single-arm study investigates the impact of a 12-week Multimodal Acoustic Therapy (MAT) intervention followed by a 12-week follow-up period on both objective and subjective auditory perception in pediatric cochlear implant users.
The group in the trial
- InterventionTreatment being tested
Device: Auditory rehabilitation application Application: Wowfit
Treatment: Mobile Auditory Rehabilitation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Single-Center, Single-Arm Exploratory Study to Evaluate the Impact of Multimodal Acoustic Therapy (MAT) on Objective and Subjective Auditory Perception During a 12-Week Intervention and a 12-Week Follow-Up in Pediatric and Adolescent Cochlear Implant Users
- Plain-language title
- Mobile listening therapy for young people with cochlear implantsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07297524, who can take part
- Record updated
- 22 December 2025